logo-loader
viewAdvanced Oncotherapy PLC

Advanced Oncotherapy ups size of open offer as investors snap up shares

Most of the key parts of Advanced Onco’s LIGHT system for Harley Street have been manufactured

Advanced Oncotherapy PLC -

Advanced Oncotherapy PLC (LON:AVO) has bumped up the size of an open offer by 16% as investors clamoured for shares in the proton beam therapy specialist.

Issued at 40p per share, the amount raised through the offer went up £2.9mln from £2.5mln and follows £18.4mln Advanced Oncotherapy raised in July through debt and a share subscription to fund its new LIGHT cancer treatment system.

The company confirmed it expects to have everything on-site at its new Harley Street centre by the end of the year.

Most of the key parts of Advanced Onco’s LIGHT system for Harley Street have been manufactured, with attention now turning towards verification and validation as part of the regulatory process.

The company added it has been able to install its system without significant building alterations due to its modular design and relatively low weight.

Proton therapy is an extremely form of radiotherapy that avoids the damage to surrounding tissue caused by traditional treatments.

 Nicolas Serandour, chief executive, said: “Focusing on the high energy testing of the LIGHT proton therapy system in compliance with the highest standards for safety and product performance will allow us to secure the approval of the medical device file and to make LIGHT available for first patient treatment.” 

Serandour predicts 9,000 additional treatment rooms will be needed by 2040 to meet the demand for proton therapy with the market rapidly approaching an inflection point.

Losses in the half-year to June were £11.2mln (£11.5mln).

Shares rose 6% to 42.5p.

Quick facts: Advanced Oncotherapy PLC

Price: 37.99 GBX

LSE:AVO
Market: LSE
Market Cap: £92.64 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Advanced Oncotherapy PLC named herein, including the promotion by the Company of Advanced Oncotherapy PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: VR Education's ENGAGE platform to be included in new 5G VR...

Headlines from the Proactive UK newsroom. VR Education’s (LON:VRE) Engage platform has been chosen as an embedded title in a new 5G virtual reality headset being developed by a consortium of Deutsche Telekom, Qualcomm and XRSPACE. The new headset is due to launch in...

1 week, 5 days ago

RNS

Holding(s) in Company

1 week, 6 days ago

Total Voting Rights

2 weeks, 3 days ago

Holding(s) in Company

2 weeks, 4 days ago

Total Voting Rights

on 6/11/19

Change of Broker

on 10/10/19

Total Voting Rights

on 30/9/19

2 min read